Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02780869 · ClinicalTrials.gov registry record · NA
HEMOBLAST Pivotal Clinical Investigation
A NA study, sponsored by Biom'Up France SAS.
- Completed
- Registry status
- NA
- Development phase
- 258
- Enrollment target
NCT02780869: Completed NA study, sponsored by Biom'Up France SAS.
NCT02780869 is a NA study that has completed, run by Biom'Up France SAS. The registered enrollment target is 258 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02780869, a NA study, has completed, sponsored by Biom'Up France SAS.
- COMPLETED
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
Study Summary
The purpose of this prospective, randomized, controlled study is to evaluate the safety and efficacy of a new hemostatic device (HEMOBLAST™ Bellows) compared to a control device, absorbable gelatin sponge USP with thrombin.
Primary Outcome
The proportion of subjects achieving hemostasis at 6 minutes post-hemostat application was calculated. Hemostasis was defined as a grade of 0 (None/Dry) on the Surface Bleeding Severity Scale, with additional grades, ranging from 1 (Minimal/Oozing) to 5 (Extreme/Gushing), considered a failure of hemostasis.
Interventions
- DEVICE HEMOBLAST Bellows
- DEVICE Absorbable gelatin sponge, USP with thrombin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2016-07-18 |
| Est. Completion | 2017-03-27 |
| Phase | NA |
What the finished NCT02780869 record still lists
NCT02780869 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which HEMOBLAST Bellows is the first listed.
NCT02780869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02780869 about?
NCT02780869 is a clinical study titled "HEMOBLAST Pivotal Clinical Investigation". The purpose of this prospective, randomized, controlled study is to evaluate the safety and efficacy of a new hemostatic device (HEMOBLAST™ Bellows) compared to a control device, absorbable gelatin sponge USP with thrombin.
What is the current status of trial NCT02780869?
This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2016-07-18. Estimated completion is 2017-03-27.
What interventions are being tested in trial NCT02780869?
The interventions under investigation include: HEMOBLAST Bellows (DEVICE), Absorbable gelatin sponge, USP with thrombin (DEVICE).
Who is sponsoring clinical trial NCT02780869?
This trial is sponsored by Biom'Up France SAS, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02780869's enrollment target sits among peer trials
258 402nd of 2000 higher than 1,598 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI